TNF alpha Antikörper (AA 78-234)
-
- Target Alle TNF alpha Antikörper anzeigen
- TNF alpha (Tumor Necrosis Factor alpha (TNF alpha))
-
Bindungsspezifität
- AA 78-234
-
Reaktivität
- Rind (Kuh)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TNF alpha Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Rind (Kuh)
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Bovine Tumor necrosis factor protein (78-234AA)
- Isotyp
- IgG
- Top Product
- Discover our top product TNF alpha Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- TNF alpha (Tumor Necrosis Factor alpha (TNF alpha))
- Andere Bezeichnung
- TNF (TNF alpha Produkte)
- Hintergrund
- TNF antibody, TNFA antibody, TNFSF2 antibody, Tumor necrosis factor antibody, Cachectin antibody, TNF-alpha antibody, Tumor necrosis factor ligand superfamily member 2 antibody, TNF-a) [Cleaved into: Tumor necrosis factor antibody, membrane form antibody, N-terminal fragment antibody, NTF), Intracellular domain 1 antibody, ICD1), Intracellular domain 2 antibody, ICD2), C-domain 1, C-domain 2, Tumor necrosis factor antibody, soluble form] antibody
- UniProt
- Q06599
- Pathways
- NF-kappaB Signalweg, Apoptose, Caspase Kaskade in der Apoptose, TLR Signalweg, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Inflammasome
-